‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
For much of her early career, Shobie Ramakrishnan called Silicon Valley home. GSK’s chief digital and technology officer ...
GlobalData on MSN1mon
GSK pumps up to $800m for US manufacturing site upgrade
The funding, which brings GSK’s expenditure in US manufacturing capabilities close to $1.3bn, will establish a new vaccines ...
FierceBiotech13d
GSK inks 2nd neuro pact in weeks, this time with Danish biotech Muna in Alzheimer's
GSK has penned another neuroscience pact, this time with Danish biotech Muna Therapeutics. | GSK has penned another ...
Yahoo Finance13d
GSK taps a startup for shot at Alzheimer’s drug
Once the companies are satisfied with the target, GSK will be in charge of taking the programs forward. It will lead drug ...
FiercePharma12d
Fierce Pharma Asia—Sanofi's $1B manufacturing base; GSK's ADC deal, Shingrix recalibration in China
Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...
Pharmaceutical Technology on MSN1d
GSK’s lung cancer therapy gains EMA PRIME designation
GSK’s GSK’227 has gained Priority Medicines (PRIME) designation from the EMA for the treatment of relapsed ES-SCLC.
BioSpace7d
Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More
GSK, Gilead and Arcellx, Vertex and more present new data at the American Society of Hematology annual meeting just as sickle cell therapies Casgevy and Lyfgenia have a new outcomes-based payment ...
biopharma-reporter8d
GSK and Muna Therapeutics partner to develop new treatments for Alzheimer’s
The partnership revolves around Muna Therapeutics’ technology platform, which employs a spatial multi-omics approach to ...
alzheimersnewstoday12d
Muna, GSK partner to develop targets for Alzheimer’s treatments
Muna will take the lead in identifying and validating new Alzheimer’s targets, while GSK will be responsible for the ...